Disclosure: Some links in this article are affiliate links. We may earn a commission if you make a purchase, at no extra cost to you. Our recommendations are based on our own independent research and are not influenced by commissions. Read our full affiliate policy.
Medical Disclaimer: The content on this page is for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any supplement, treatment, or wellness regimen, or making changes to your health routine. Individual results may vary. If you are pregnant, nursing, taking medication, or managing a medical condition, talk to your doctor first.

Combined exercise and creatine supplementation may support blood sugar control in older adults, according to a 2026 Nutrients review. The evidence is early, but the metabolic angle is drawing genuine scientific interest beyond creatine’s established sports-performance role.

For decades, creatine has been studied almost exclusively in the context of muscle strength, power output, and athletic recovery. The newer research points to potential metabolic benefits, particularly around how the body handles glucose after a meal and how muscle tissue responds to exercise in older populations. Understanding what the science actually shows (and where it falls short) matters if you’re considering creatine for reasons beyond the gym.

This article covers what a 2026 Nutrients review found, how that fits alongside earlier evidence, who the research actually applies to, and what to discuss with your doctor before adding creatine to your routine.


What Creatine Is and How It Works

Creatine is a naturally occurring compound your body synthesises from amino acids, primarily in the liver, kidneys, and pancreas. It is also found in red meat and seafood. The body stores creatine mostly in skeletal muscle, where it plays a core role in rapid energy production, particularly during short bursts of high-intensity activity.

When muscle cells need quick energy, they draw on phosphocreatine (the stored form) to rapidly regenerate ATP, the molecule that powers cellular work. Supplementing with creatine (most commonly creatine monohydrate) raises the muscle’s phosphocreatine reservoir, which is why it is one of the most researched performance supplements in existence.

What is less widely known is that muscle tissue is also the body’s primary site of glucose disposal after a meal. When muscle cells take up glucose efficiently, blood sugar levels stabilise more readily. This is the biological bridge that researchers have begun exploring: if creatine supports muscle energy metabolism, could it also influence how muscle handles glucose?


What the 2026 Research Actually Shows

A review published in Nutrients in 2026 examined the combined effect of exercise and creatine supplementation on metabolic markers in older adults. The review found that when creatine was paired with structured resistance exercise, the combination was associated with improvements in glucose uptake by muscle tissue and in markers of muscle protein synthesis. Importantly, the benefit appeared to be additive: creatine plus exercise showed stronger associations than either alone in several of the studies reviewed.

These findings align with a plausible mechanism. Creatine is thought to support GLUT4 translocation — the process by which muscle cells move glucose transporters to the cell surface in response to insulin and exercise. More GLUT4 activity means muscle can absorb more glucose from the bloodstream, which may support post-meal blood sugar management.

Earlier research had already hinted at this. A 2011 study in Medicine & Science in Sports & Exercise found creatine supplementation was associated with improved glycaemic response during a glucose tolerance test when combined with exercise in healthy adults. A smaller body of work has looked at creatine’s potential effects in people with type 2 diabetes, with some studies reporting modest improvements in glycated haemoglobin (HbA1c) and post-meal glucose; however, sample sizes have been small and results inconsistent across trials.

The 2026 Nutrients review is notable because it specifically focused on older adults: a population where both muscle loss (sarcopenia) and glucose regulation tend to decline together, and where the interaction between the two is increasingly well understood. NutraIngredients reported on this review as part of growing scientific conversation around creatine’s role in healthy ageing beyond muscle mass.


How This Differs From Creatine’s Established Role

Creatine’s performance benefits are well established and replicated across hundreds of trials: it increases strength, supports lean mass gains during resistance training, and may improve recovery between exercise bouts. These effects are not in question.

The blood sugar angle is different in character. Where performance benefits are consistent and well-quantified, the metabolic evidence is still accumulating. Researchers are exploring a biological plausibility that makes sense in theory and has early supporting data, but has not yet been tested at the scale or rigour needed to draw firm conclusions for clinical use.

This distinction matters for how you interpret any coverage of this topic. Saying creatine “may support” post-meal glucose management as part of an exercise programme is a fair representation of the current evidence. Saying it “controls blood sugar” or “treats metabolic conditions” would go beyond what the research supports.


Who Might Benefit Most (and Who the Research Applies To)

The 2026 review and most of the supporting research focused on specific groups. Understanding who the studies actually enrolled helps set realistic expectations.

  • Older adults engaged in resistance training. The clearest signal in the evidence is for people over 55 who are already doing (or starting) structured exercise. The metabolic and muscle-health benefits appear to work together in this population.
  • People with age-related muscle loss. Sarcopenia (gradual muscle loss with ageing) is directly linked to declining glucose regulation. Supporting muscle health through exercise and creatine may have downstream effects on metabolic markers.
  • Physically active adults looking to support metabolic health alongside performance. The exercise component appears to be essential in all of the positive findings; creatine alone, without exercise, does not carry the same signal.

The evidence is weakest or absent for sedentary individuals, children and adolescents, and people seeking creatine as a standalone metabolic intervention without exercise. If exercise is not part of the picture, there is little basis in the current research to expect meaningful blood sugar benefits from creatine alone.


Important Limitations and What We Don’t Know Yet

The science here is genuinely early. Before drawing conclusions, here is what the current research cannot yet tell us:

  • Most studies are small. Many of the trials examining creatine and glucose regulation enrolled fewer than 50 participants. Effect sizes can look strong in small studies and diminish when tested at larger scale.
  • Long-term effects are unclear. Most trials run for 8-16 weeks. Whether metabolic benefits persist over months or years, or whether they depend on continued supplementation combined with ongoing exercise, is not established.
  • Confounders are difficult to control. Diet, baseline fitness, age, and individual glucose metabolism all influence the outcomes. Studies often cannot fully separate the effect of creatine from the effect of the exercise programme it accompanies.
  • Clinical populations need separate study. Most positive findings come from healthy older adults or recreationally active people. The research in people with diagnosed insulin resistance or type 2 diabetes is limited and inconsistent enough that it cannot support specific clinical recommendations.
  • Mechanism vs. outcome. Some studies show changes in biological markers (like GLUT4 activity or post-meal glucose curves) rather than meaningful health outcomes. A change in a marker is not the same as a confirmed health benefit.

Researchers call this a “promising but preliminary” area for good reason. The 2026 Nutrients review itself calls for larger, longer, and more rigorously controlled trials before clinical guidance can be updated.


When Creatine Is Not Right for You

Creatine is generally well-tolerated in healthy adults, but there are specific situations where caution or medical consultation is warranted. This section covers the most important ones.

Medication Interactions

If you take medications to manage blood sugar (including metformin, sulfonylureas, insulin, or other glucose-lowering drugs), adding creatine may theoretically influence how your body handles glucose. Because the potential for additive effects on blood sugar exists, anyone on diabetes medications should discuss creatine with their prescribing physician before starting supplementation. Dose adjustments or closer monitoring may be appropriate.

Creatine may also interact with diuretics (water pills). Some diuretics alter kidney function and electrolyte balance; because creatine draws water into muscle cells, combining the two may increase the risk of dehydration or put additional strain on the kidneys. Consult your doctor if you take diuretics of any kind.

Creatine has known interactions with nephrotoxic drugs (medications that can stress the kidneys, including some NSAIDs and certain antibiotics). If you take any medication with kidney-related considerations, check with your healthcare provider first.

Kidney Disease or Reduced Kidney Function

Creatine is processed and excreted by the kidneys. In healthy adults this presents no known problem at standard doses. However, for people with existing kidney disease, chronic kidney disease (CKD), or reduced kidney function, creatine supplementation is generally contraindicated. Creatine metabolism raises creatinine levels in the blood (a standard marker for kidney health), which can complicate monitoring and potentially worsen underlying conditions. If you have any history of kidney problems, do not use creatine without explicit guidance from a nephrologist or your GP.

Pre-Diabetes and Blood Sugar Conditions

If you have been told you have pre-diabetes, impaired fasting glucose, or insulin resistance, the emerging research may feel relevant; it also means your metabolic situation warrants medical supervision. The studies showing potential metabolic benefit used controlled exercise programmes alongside creatine; replicating this independently without monitoring carries uncertainty. A conversation with your doctor is the appropriate starting point.

Pregnancy and Nursing

There is insufficient safety data on creatine supplementation during pregnancy or breastfeeding. Until research establishes safety for this group, creatine is best avoided during pregnancy and nursing unless a healthcare provider specifically recommends it.

Adolescents and Young People

Creatine research has largely been conducted in adults. Its use in people under 18 is not well studied for either metabolic or performance outcomes. Paediatric and adolescent use is best discussed with a doctor rather than undertaken independently.


Tools and Resources That Can Help

If the research on creatine and metabolic health has you thinking more broadly about exercise, recovery, and how you monitor your wellbeing, a few resources on this site may be useful starting points.

Resistance training is central to the evidence base: the metabolic benefits in the reviewed studies were not found from creatine alone, but from creatine paired with structured exercise. If you are setting up or improving your home training space, our best home gym equipment guide for 2026 covers the equipment options across different budgets and goals.

Monitoring how your body responds to exercise and lifestyle changes is also worth considering, especially if metabolic health is a goal. Our fitness trackers and smartwatches roundup for 2026 compares wearables that track heart rate variability, recovery, and activity: data points that can help you and your doctor assess whether a new exercise routine is working.

Finally, for those exploring broader nutritional support alongside creatine, our greens powders roundup for 2026 covers evidence-based options for filling nutritional gaps, relevant if you are restructuring your diet alongside a new supplement and exercise protocol.


Frequently Asked Questions

Does creatine lower blood sugar?

Current research does not support saying creatine “lowers blood sugar” as a standalone effect. Some studies suggest creatine combined with exercise may support more efficient post-meal glucose disposal by muscle tissue, but the effect is associated with exercise rather than creatine alone, and the evidence remains preliminary. Creatine is not a blood sugar medication.

Is creatine safe for people with type 2 diabetes?

The limited research available has not shown harmful effects in people with type 2 diabetes at standard doses, but it has also not established clear benefit. People with type 2 diabetes are typically on medications that affect blood sugar, and creatine may interact with how those medications work. Anyone managing type 2 diabetes should discuss creatine with their doctor before using it.

What form of creatine is best supported by the research?

Creatine monohydrate is the form used in the vast majority of published studies, including those examining metabolic effects. Other forms (creatine HCl, buffered creatine, etc.) are marketed with various claims, but they lack the same depth of research. The metabolic evidence base, such as it is, applies primarily to monohydrate.

How much creatine do the studies use?

Most studies examining metabolic effects used standard supplementation protocols: a loading phase of 20g per day for 5-7 days (divided into 4-5 doses), followed by a maintenance dose of 3-5g per day. Some studies skip the loading phase and use 3-5g per day from the outset. Individual needs and tolerability vary; a healthcare provider can help determine what is appropriate for your situation.

Can older adults use creatine safely?

Research in healthy older adults (typically 55-75 years) has generally found creatine to be well tolerated at standard doses, particularly when combined with resistance exercise. That said, older adults are more likely to have kidney-related health considerations or to be taking medications that interact with creatine. A conversation with a GP before starting is a sensible step, especially for anyone over 65.

Does creatine help with insulin sensitivity?

Some research suggests creatine may support insulin signalling in muscle tissue, specifically by influencing GLUT4 activity, a protein involved in how cells take up glucose in response to insulin. Whether this translates to meaningful improvements in overall insulin sensitivity in humans across varied populations is not yet established. The evidence is mechanistically interesting but not yet clinically conclusive.


Bottom Line

A 2026 Nutrients review adds to a growing body of research suggesting that creatine, when combined with resistance exercise, may offer metabolic benefits beyond muscle and performance, particularly in older adults. The proposed mechanism (improved glucose uptake by muscle through enhanced GLUT4 activity) is plausible and supported by early data. But the research is preliminary: studies are small, long-term outcomes are not established, and the benefit appears to depend on exercise being part of the equation.

For healthy older adults already engaged in resistance training, creatine monohydrate is a well-studied, generally well-tolerated supplement worth discussing with a healthcare provider if metabolic health is a goal alongside fitness. For anyone with kidney disease, existing blood sugar conditions, or who is taking glucose-lowering or diuretic medications, that conversation with a doctor is not optional — it is a prerequisite. The metabolic science around creatine is worth watching as larger trials emerge; for now, the honest answer is that the signal is promising, not proven.